Status Quo and Reflections of Development of Integrative Coronary Heart Disease Clinical Practice Guidelines
- VernacularTitle:冠心病中西医结合临床实践指南研制现状及思考
- Author:
Chengyu LI
1
;
Yaolong CHEN
;
Jiayuan HU
;
Hongcai SHANG
Author Information
- Keywords: Coronary heart disease; integrative medicine; clinical practice guideline; RIGHT statement
- From: World Science and Technology-Modernization of Traditional Chinese Medicine 2018;20(12):2101-2108
- CountryChina
- Language:Chinese
- Abstract: Objective: Through analyzing development statue of integrative coronary heart disease clinical practice guidelines, we aim to provide a reference baseline for the future study. Methods: Databases including CBM, CNKI, WanFang, VIP were searched for published integrative coronary heart disease clinical practices. The website medlive.cn was also used as supplementary. The reporting tool for clinical practice guidelines RIGHT statement was used to evaluate the reporting quality. Results: A total of nine relevant clinical practice guidelines or experts consensuses were included, covering five integrative treatment therapy guidelines of PCI or CABG perioperative period, three myocardial infarction guidelines and one atherosclerosis guideline. Experts consensus methods were adopted in seven guidelines, the remining two guidelines used the evidence-based guidelines development methods. The evaluation of RIGHT statements showed that most guidelines reported complete information in"Basic information"and"Background"domain, however, they usually failed to provide enough description in"Evidence", "Recommendations", "Review and quality assurance", "Funding and declaration and management of interests"and"Other information"parts. Conclusion: Although some achievements have been reached in the development of integrative coronary heart disease clinical practice guidelines, the development methods and quality of reporting still needs further improvements. Researchers should explore more specific Chinese medicine guideline development methods and tools in the future.